References

Akaike H. A New Look at the Statistical Model Identification IEEE Trans. Automat. Contr 1974: 716-23.

Bohnen NI, Djang DSW, Herholz K, Anzai Y, Minoshima S. Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: A review of the recent literature. J Nucl Med 2012; 53: 59-71.

Diehl-Schmid J, Grimmer T, Drzezga A, Bornschein S, Riemenschneider M, Forstl H, et al. Decline of cerebral glucose metabolism in frontotemporal dementia: A longitudinal 18F-FDG-PET-study. Neurobiol Aging 2007; 28: 42-50.

Eckert T, Eidelberg D. The role of functional neuroimaging in the differential diagnosis of idiopathic parkinson’s disease and multiple system atrophy. Clin Auton Res 2004; 14: 84-91.

Eckert T, Barnes A, Dhawan V, Frucht S, Gordon MF, Feigin AS, et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 2005; 26: 912-21.

Eckert T, Tang C, Ma Y, Brown N, Lin T, Frucht S, et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord 2008.

Eidelberg D. Metabolic brain networks in neurodegenerative disorders: A functional imaging approach. Trends Neurosci 2009; 32: 548-57.

Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, et al. The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 1994; 14: 783-801.

Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR, et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and alzheimer’s disease. Brain 2007; 130: 2616-35.

Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71: 670-6.

Habeck C, Foster NL, Perneczky R, Kurz A, Alexopoulos P, Koeppe RA, et al. Multivariate and univariate neuroimaging biomarkers of alzheimer’s disease. Neuroimage 2008; 40: 1503-15.

Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, et al. Preliminary NINDS neuropathologic criteria for steele-richardson-olszewski syndrome (progressive supranuclear palsy). Neurology 1994; 44: 2015-9.

Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frolich L, et al. Discrimination between alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002; 17: 302-16.

Huang C, Mattis P, Tang C, Perrine K, Carbon M, Eidelberg D. Metabolic brain networks associated with cognitive function in parkinson’s disease. Neuroimage 2007a; 34: 714-23.

Huang C, Eidelberg D, Habeck C, Moeller J, Svensson L, Tarabula T, et al. Imaging markers of mild cognitive impairment: Multivariate analysis of CBF SPECT. Neurobiol Aging 2007b; 28: 1062-9.

Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, et al. Changes in network activity with the progression of parkinson’s disease. Brain 2007c; 130: 1834-46.

Jeong Y, Cho SS, Park JM, Kang SJ, Lee JS, Kang E, et al. 18F-FDG PET findings in frontotemporal dementia: An SPM analysis of 29 patients. J Nucl Med 2005; 46: 233-9.

Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, Duffy JR, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006; 66: 41-8.

Leenders KL, Wolfson L, Jones T. Cerebral blood flow and oxygen metabolism measurement with positron emission tomography in parkinson’s disease. Monogr Neural Sci 1984a; 11: 180-6.

Leenders KL, Gibbs JM, Frackowiak RS, Lammertsma AA, Jones T. Positron emission tomography of the brain: New possibilities for the investigation of human cerebral pathophysiology. Prog Neurobiol 1984b; 23: 1-38.

Leenders KL, Wolfson L, Gibbs JM, Wise RJ, Causon R, Jones T, et al. The effects of L-DOPA on regional cerebral blood flow and oxygen metabolism in patients with parkinson’s disease. Brain 1985; 108 ( Pt 1): 171-91.

Leenders KL, Salmon EP, Tyrrell P, Perani D, Brooks DJ, Sager H, et al. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with parkinson’s disease. Arch Neurol 1990; 47: 1290-8.

Leenders KL, Palmer AJ, Quinn N, Clark JC, Firnau G, Garnett ES, et al. Brain dopamine metabolism in patients with parkinson’s disease measured with positron emission tomography. J Neurol Neurosurg Psychiatry 1986; 49: 853-60.

Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, et al. Movement disorders society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 2003; 18: 467-86.

Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (steele-richardson-olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1-9.

Ma Y, Tang C, Moeller JR, Eidelberg D. Abnormal regional brain function in parkinson’s disease: Truth or fiction? Neuroimage 2009; 45: 260-6.

Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D. Abnormal metabolic network activity in parkinson’s disease: Test-retest reproducibility. J Cereb Blood Flow Metab 2007a; 27: 597-605.

Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D. Abnormal metabolic network activity in parkinson’s disease: Test-retest reproducibility. J Cereb Blood Flow Metab 2007b; 27: 597-605.

Ma Y, Huang C, Dyke JP, Pan H, Alsop D, Feigin A, et al. Parkinson’s disease spatial covariance pattern: Noninvasive quantification with perfusion MRI. J Cereb Blood Flow Metab 2010a; 30: 505-9.

McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with lewy bodies (DLB): Report of the consortium on DLB international workshop. J Alzheimers Dis 2006; 9: 417-23.

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease 35. Neurology 1984; 34: 939-44.

McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: Report of the work group on frontotemporal dementia and pick’s disease. Arch Neurol 2001; 58: 1803-9.

Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL, Kuhl DE. Alzheimer’s disease versus dementia with lewy bodies: Cerebral metabolic distinction with autopsy confirmation. Ann Neurol 2001; 50: 358-65.

Moeller JR, Strother SC, Sidtis JJ, Rottenberg DA. Scaled subprofile model: A statistical approach to the analysis of functional patterns in positron emission tomographic data. J Cereb Blood Flow Metab 1987; 7: 649-58.

Moeller JR, Nakamura T, Mentis MJ, Dhawan V, Spetsieres P, Antonini A, et al. Reproducibility of regional metabolic covariance patterns: Comparison of four populations. J Nucl Med 1999; 40: 1264-9.

Poston KL, Eidelberg D. Network biomarkers for the diagnosis and treatment of movement disorders. Neurobiol Dis 2009; 35: 141-7.

Poston KL, Tang CC, Eckert T, Dhawan V, Frucht S, Vonsattel J-, et al. Network correlates of disease severity in multiple system atrophy. Neurology 2012; 78: 1237-44.

Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, et al. The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 1979; 44: 127-37.

Spetsieris PG, Eidelberg D. Scaled subprofile modeling of resting state imaging data in parkinson’s disease: Methodological issues. Neuroimage 2010.

Spetsieris PG, Dhawan V, Eidelberg D. Three-fold cross-validation of parkinsonian brain patterns. Conf Proc IEEE Eng Med Biol Soc 2010; 2010: 2906-9.

Spetsieris PG, Ma Y, Dhawan V, Eidelberg D. Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features. Neuroimage 2009; 45: 1241-52.

Steele JC, Richardson J,Olszewski J. Progressive supranuclear palsy: A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964; 10: 333-59.

Tang CC, Poston KL, Dhawan V, Eidelberg D. Abnormalities in metabolic network activity precede the onset of motor symptoms in parkinson’s disease. J Neurosci 2010a; 30: 1049-56.

Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, et al. Differential diagnosis of parkinsonism: A metabolic imaging study using pattern analysis. Lancet Neurol 2010b; 9: 149-58.

Teune LK, Bartels AL, de Jong BM, Willemsen AT, Eshuis SA, de Vries JJ, et al. Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord 2010; 25: 2395-404.

Teune LK, Renken RJ, Mudali D, et al. Validation of parkinsonian disease-related metabolic brain patterns. Mov Disord 2013;28:547-551.

Teune LK, Strijkert F, Renken RJ, et al. The Alzheimer’s disease-related glucose metabolic brain pattern. Under review.

Teune LK, Bartels AL, Leenders KL (2013). FDG-PET Imaging in Neurodegenerative Brain Diseases, Functional Brain Mapping and the Endeavor to Understand the Working Brain, Dr. Francesco Signorelli (Ed.), ISBN: 978-953-51-1160-3, InTech, DOI: 10.5772/56505. Available from: http://www.intechopen.com/books/functional-brain-mapping-and-the-endeavor-to-understand-the-working-brain/fdg-pet-imaging-in-neurodegenerative-brain-diseases

Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: A review of 203 pathologically proven cases. Mov Disord 1997; 12: 133-47.

Advertisements

Create a website or blog at WordPress.com

Up ↑

Create your website at WordPress.com
Get started